CTA-PB — E. I. du Pont de Nemours and Company

Summary of Corteva Agriscience Q3 2025 Earnings Call

1. Key Financial Results and Metrics

• Q3 Performance: Organic sales increased by 11% year-over-year, with a 12% rise in volumes. Operating EBITDA was up 19% year-over-year, reaching over $3.4 billion year-to-date, with a margin improvement of 320 basis points to over 25%.
• Full-Year Guidance: Corteva raised its operating EBITDA guidance to a range of $3.8 billion to $3.9 billion, reflecting a 14% growth at the midpoint. Operating EPS is now projected at $3.25 to $3.35 per share, a 28% increase year-over-year. Free cash flow is expected to be approximately $1.9 billion.
• Cost Savings: The company achieved over $600 million in controllable benefits, surpassing previous estimates.

2. Strategic Updates and Business Highlights

• Separation Announcement: Corteva plans to separate into two public companies by the second half of 2026, focusing on distinct growth opportunities in Seed and Crop Protection.
• Seed Business: The Seed business is performing well, with significant productivity gains and a projected increase in market share, particularly in North America and Brazil. Conkesta is expected to achieve double-digit market penetration in Brazil by 2026.
• Crop Protection Business: The Crop Protection segment is seeing strong demand for differentiated technologies, with a projected high single-digit EBITDA growth for the year. The launch of new products, including the next-gen insecticide Varpelgo, is anticipated to drive future revenue.

3. Forward Guidance and Outlook

• 2026 Outlook: Corteva anticipates low single-digit growth in the Crop Protection industry, with a projected operating EBITDA of $4.1 billion for Corteva, representing mid-single-digit growth year-over-year. The company remains optimistic about market demand for grains and oilseeds.
• Investment in Innovation: Continued investment in R&D is planned, with a target of maintaining R&D spending at 6-7% of revenue.

4. Bad News, Challenges, or Points of Concern

• Competitive Pricing Dynamics: The Crop Protection market is experiencing competitive pricing pressures, particularly in Brazil, which may impact margins. While pricing is stabilizing globally, challenges remain in specific regions.
• Credit Market Conditions: Higher borrowing costs and increased bankruptcies among growers in Latin America could pose risks, although Corteva has managed its accounts receivable exposure effectively.
• Dis-synergies from Separation: The separation is expected to incur dis-synergies estimated at $80 million to $100 million, which the company is actively working to minimize.

5. Notable Q&A Insights

• Market Positioning: Corteva's Crop Protection business is well-positioned with a strong R&D pipeline valued at $9 billion, focusing on differentiated products that command premium pricing.
• Biologicals Growth: Biologicals are expected to continue growing, with sales projected to reach $600 million this year, reflecting strong demand and successful market entry strategies.
• M&A Considerations: Corteva is open to M&A opportunities in the biologicals space, recognizing the fragmented nature of the market and the potential for strategic partnerships.
• Acreage Shifts: A potential shift of acreage from corn to soybeans is anticipated, with a sensitivity of $10 million EBITDA impact for every million acres shifted, although this is factored into the company's projections.

This summary encapsulates the key points from Corteva's Q3 2025 earnings call, highlighting financial performance, strategic initiatives, and future outlook while addressing challenges and insights from the Q&A session.